| Vashisht Venkata Madabhushi, MD | |
|
800 Rose St # C-246, Lexington, KY 40536-7001 | |
| (859) 323-6162 | |
| Not Available |
| Full Name | Vashisht Venkata Madabhushi |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 800 Rose St # C-246, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134581622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | R4129 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vashisht Venkata Madabhushi, MD 800 Rose St, Lexington, KY 40536-7001 Ph: () - | Vashisht Venkata Madabhushi, MD 800 Rose St # C-246, Lexington, KY 40536-7001 Ph: (859) 323-6162 |
News Archive
Children suffering from a cancer of the nervous system could benefit from a potential new treatment, thanks to an international team led by researchers at the University of Kent and at the Institute of Medical Virology at the Goethe-University, Frankfurt am Main, Germany.
The health reform law will get millions of Americans coverage in 2014. Until then, Congress offered Iowa up to $35 million to provide temporary insurance for people whose health prevent them from buying coverage on their own. Iowa botched the entire concept behind the high-risk pool, and state and federal officials stood by and failed to take corrective action.
Patients can spend up to six years waiting for a kidney transplant. Even when they do receive a transplant, up to 20 percent of patients will experience rejection.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria today welcomed the payment by Japan of the second and final tranche of its total 2012 contribution of US$343 million, the highest annual amount that Japan has ever made in 10 years of vigorous support for the Global Fund," a Global Fund press release reports.
Idera Pharmaceuticals today announced that 48% of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in Psoriasis Area Severity Index (PASI) scores of 35% to 90% from baseline at the completion of a randomized, double-blind, placebo-controlled Phase 2a clinical trial of two dose levels of IMO-3100 administered for four weeks, with a four-week follow-up period.
› Verified 4 days ago
Keith Menes, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2350 Regency Rd Ste A, Lexington, KY 40503 Phone: 859-278-4960 Fax: 859-523-2277 | |
Melissa Ranney Newcomb, MD Surgery Medicare: Medicare Enrolled Practice Location: Ukmc General Surgery, 800 Rose St., Lexington, KY 40536 Phone: 859-323-6346 Fax: 859-323-6840 | |
Cheryl Diana Richie, Surgery Medicare: Accepting Medicare Assignments Practice Location: 138 Leader Ave, Lexington, KY 40508 Phone: 859-323-5261 | |
Dr. Varun Jain, M.D Surgery Medicare: Medicare Enrolled Practice Location: 740 S Limestone Ste L104, Lexington, KY 40536 Phone: 859-257-3253 Fax: 859-323-1203 | |
Wanda Lam, MD Surgery Medicare: Medicare Enrolled Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-257-3253 Fax: 859-323-1203 | |
David J Worhunsky, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5625 | |
Veronica Morgan Jones, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Rose St Whitney Hendrickson Ste 134, Lexington, KY 40536 Phone: 859-323-6346 Fax: 859-323-6840 |